Literature DB >> 19917720

Cyclin-dependent kinase 1-mediated Bcl-xL/Bcl-2 phosphorylation acts as a functional link coupling mitotic arrest and apoptosis.

David T Terrano1, Meenakshi Upreti, Timothy C Chambers.   

Abstract

Despite detailed knowledge of the components of the spindle assembly checkpoint, a molecular explanation of how cells die after prolonged spindle checkpoint activation, and thus how microtubule inhibitors and other antimitotic drugs ultimately elicit their lethal effects, has yet to emerge. Mitotically arrested cells typically display extensive phosphorylation of two key antiapoptotic proteins, Bcl-x(L) and Bcl-2, and evidence suggests that phosphorylation disables their antiapoptotic activity. However, the responsible kinase has remained elusive. In this report, evidence is presented that cyclin-dependent kinase 1 (CDK1)/cyclin B catalyzes mitotic-arrest-induced Bcl-x(L)/Bcl-2 phosphorylation. Furthermore, we show that CDK1 transiently and incompletely phosphorylates these proteins during normal mitosis. When mitosis is prolonged in the absence of microtubule inhibition, Bcl-x(L) and Bcl-2 become highly phosphorylated. Transient overexpression of nondegradable cyclin B1 caused apoptotic death, which was blocked by a phosphodefective Bcl-x(L) mutant but not by a phosphomimetic Bcl-x(L) mutant, confirming Bcl-x(L) as a key target of proapoptotic CDK1 signaling. These findings suggest a model whereby a switch in the duration of CDK1 activation, from transient during mitosis to sustained during mitotic arrest, dramatically increases the extent of Bcl-x(L)/Bcl-2 phosphorylation, resulting in inactivation of their antiapoptotic function. Thus, phosphorylation of antiapoptotic Bcl-2 proteins acts as a sensor for CDK1 signal duration and as a functional link coupling mitotic arrest to apoptosis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19917720      PMCID: PMC2812246          DOI: 10.1128/MCB.00882-09

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  38 in total

1.  Identification of the major phosphorylation site in Bcl-xL induced by microtubule inhibitors and analysis of its functional significance.

Authors:  Meenakshi Upreti; Elena N Galitovskaya; Rong Chu; Alan J Tackett; David T Terrano; Susana Granell; Timothy C Chambers
Journal:  J Biol Chem       Date:  2008-10-30       Impact factor: 5.157

2.  Involvement of microtubules in the regulation of Bcl2 phosphorylation and apoptosis through cyclic AMP-dependent protein kinase.

Authors:  R K Srivastava; A R Srivastava; S J Korsmeyer; M Nesterova; Y S Cho-Chung; D L Longo
Journal:  Mol Cell Biol       Date:  1998-06       Impact factor: 4.272

3.  Biochemical and cellular effects of roscovitine, a potent and selective inhibitor of the cyclin-dependent kinases cdc2, cdk2 and cdk5.

Authors:  L Meijer; A Borgne; O Mulner; J P Chong; J J Blow; N Inagaki; M Inagaki; J G Delcros; J P Moulinoux
Journal:  Eur J Biochem       Date:  1997-01-15

Review 4.  Coupling cell division and cell death to microtubule dynamics.

Authors:  P K Sorger; M Dobles; R Tournebize; A A Hyman
Journal:  Curr Opin Cell Biol       Date:  1997-12       Impact factor: 8.382

5.  Raf-1/bcl-2 phosphorylation: a step from microtubule damage to cell death.

Authors:  M V Blagosklonny; P Giannakakou; W S el-Deiry; D G Kingston; P I Higgs; L Neckers; T Fojo
Journal:  Cancer Res       Date:  1997-01-01       Impact factor: 12.701

6.  Inactivation of Bcl-2 by phosphorylation.

Authors:  S Haldar; N Jena; C M Croce
Journal:  Proc Natl Acad Sci U S A       Date:  1995-05-09       Impact factor: 11.205

7.  Taxol-induced p34cdc2 kinase activation and apoptosis inhibited by 12-O-tetradecanoylphorbol-13-acetate in human breast MCF-7 carcinoma cells.

Authors:  S C Shen; T S Huang; S H Jee; M L Kuo
Journal:  Cell Growth Differ       Date:  1998-01

8.  Bcl-xL is phosphorylated in malignant cells following microtubule disruption.

Authors:  M S Poruchynsky; E E Wang; C M Rudin; M V Blagosklonny; T Fojo
Journal:  Cancer Res       Date:  1998-08-01       Impact factor: 12.701

Review 9.  Specificity of receptor tyrosine kinase signaling: transient versus sustained extracellular signal-regulated kinase activation.

Authors:  C J Marshall
Journal:  Cell       Date:  1995-01-27       Impact factor: 41.582

10.  Identification of a novel Bcl-xL phosphorylation site regulating the sensitivity of taxol- or 2-methoxyestradiol-induced apoptosis.

Authors:  Aruna Basu; Subrata Haldar
Journal:  FEBS Lett       Date:  2003-03-13       Impact factor: 4.124

View more
  105 in total

1.  Stalling in mitosis and releasing the apoptotic brake.

Authors:  Manabu Kurokawa; Sally Kornbluth
Journal:  EMBO J       Date:  2010-07-21       Impact factor: 11.598

2.  Demethoxycurcumin was prior to temozolomide on inhibiting proliferation and induced apoptosis of glioblastoma stem cells.

Authors:  Lei Shi; Xifeng Fei; Zhimin Wang
Journal:  Tumour Biol       Date:  2015-04-16

3.  Systems analysis of phosphorylation-regulated Bcl-2 interactions establishes a model to reconcile the controversy over the significance of Bcl-2 phosphorylation.

Authors:  Ting Song; Peiran Wang; Xiaoyan Yu; Anhui Wang; Gaobo Chai; Yudan Fan; Zhichao Zhang
Journal:  Br J Pharmacol       Date:  2018-12-26       Impact factor: 8.739

Review 4.  Mitosis as an anti-cancer drug target.

Authors:  Anna-Leena Salmela; Marko J Kallio
Journal:  Chromosoma       Date:  2013-06-18       Impact factor: 4.316

5.  Bim vanishes in the light of a mitotic Aurora.

Authors:  L L Fava; M D Haschka; A Villunger
Journal:  Cell Death Differ       Date:  2013-12       Impact factor: 15.828

6.  Molecular analysis of functional redundancy among anti-apoptotic Bcl-2 proteins and its role in cancer cell survival.

Authors:  Joshua M Eichhorn; Sarah E Alford; Nandini Sakurikar; Timothy C Chambers
Journal:  Exp Cell Res       Date:  2014-02-17       Impact factor: 3.905

7.  Contribution of Bcl-2 phosphorylation to Bak binding and drug resistance.

Authors:  Haiming Dai; Husheng Ding; X Wei Meng; Sun-Hee Lee; Paula A Schneider; Scott H Kaufmann
Journal:  Cancer Res       Date:  2013-10-04       Impact factor: 12.701

8.  Identification of a mitotic death signature in cancer cell lines.

Authors:  Nandini Sakurikar; Joshua M Eichhorn; Sarah E Alford; Timothy C Chambers
Journal:  Cancer Lett       Date:  2013-10-04       Impact factor: 8.679

9.  Targeting BCL-xL improves the efficacy of bromodomain and extra-terminal protein inhibitors in triple-negative breast cancer by eliciting the death of senescent cells.

Authors:  Sylvia S Gayle; Jennifer M Sahni; Bryan M Webb; Kristen L Weber-Bonk; Melyssa S Shively; Raffaella Spina; Eli E Bar; Mathew K Summers; Ruth A Keri
Journal:  J Biol Chem       Date:  2018-11-27       Impact factor: 5.157

10.  Cell Cycle-Dependent Mechanisms Underlie Vincristine-Induced Death of Primary Acute Lymphoblastic Leukemia Cells.

Authors:  Anisha Kothari; Walter N Hittelman; Timothy C Chambers
Journal:  Cancer Res       Date:  2016-05-06       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.